Boston PartnersBoston Partners

Institutional investor · Portfolio as of Q3 2020

Top Holdings642 positions

Checking export access…
Activity:

JPMorgan Chase & Co

11.3M$1.1B2.0%$101.07-18.27%
8 qtrssince 2018-Q4
Increased
57

Johnson & Johnson

6.9M$1B1.9%$113.06+11.66%
8 qtrssince 2018-Q4
Increased
58

Berkshire Hathaway Inc

4M$842.3M1.5%$204.63+4.06%
8 qtrssince 2018-Q4
Decreased
0

AutoZone Inc

680,882$801.8M1.5%$973.75+20.94%
7 qtrssince 2019-Q1
Decreased
0

Eaton Corp PLC

7.8M$793.2M1.4%$68.61+34.59%
8 qtrssince 2018-Q4
Decreased
0

Bank of America Corp

31.9M$769.6M1.4%$20.82+0.30%
8 qtrssince 2018-Q4
Decreased
0

Pfizer Inc

20.5M$753.8M1.4%$27.58-6.90%
8 qtrssince 2018-Q4
Decreased
0

Halfmoon Parent Inc

3.9M$652.9M1.2%$172.95-11.88%
8 qtrssince 2018-Q4
Decreased
0

Cisco Systems Inc/Delaware

16.5M$651M1.2%$37.58-11.66%
8 qtrssince 2018-Q4
Decreased
0

BB&T Corp

16.5M$629.4M1.1%$39.74-27.22%
4 qtrssince 2019-Q4
Increased
54

Anthem Inc

2.2M$595.9M1.1%$234.63+5.11%
8 qtrssince 2018-Q4
Decreased
0

DowDuPont Inc

10.7M$594.2M1.1%$74.22-15.83%
6 qtrssince 2019-Q2
Decreased
0

Medtronic PLC

5.5M$569.6M1.0%$82.18+5.63%
8 qtrssince 2018-Q4
Decreased
0

Qorvo Inc

4.3M$549.7M1.0%$89.79+45.64%
8 qtrssince 2018-Q4
Decreased
0

Owens Corning

8M$549.5M1.0%$49.15+26.13%
8 qtrssince 2018-Q4
Decreased
0
NVSNVS
ADR

NOVARTIS AG SPONSORED ADR

6.3M$546M1.0%$66.99+3.49%
8 qtrssince 2018-Q4
Decreased
0

Huntington Bancshares Inc/OH

58.8M$539.3M1.0%$8.97-21.42%
8 qtrssince 2018-Q4
Increased
48

Best Buy Co Inc

4.8M$532.6M1.0%$49.35+74.27%
5 qtrssince 2019-Q3
Decreased
0

Dover Corp

4.8M$520.7M0.9%$86.41+16.54%
8 qtrssince 2018-Q4
Decreased
0

NXP Semiconductors NV

4.1M$508.9M0.9%$98.78+14.01%
7 qtrssince 2019-Q1
Decreased
0
$54.9B
AUM
642
Positions
Q3 2020
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+1%Q2'19$76.3B-3%Q3'19$73.8B+2%Q4'19$75.6B-33%Q1'20$50.4B+8%Q2'20$54.4B+1%Q3'20$54.9B
Activity profile
$ moved · Q3'20
New4%Increased38%Decreased56%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q4%1-4Q22%1-2Y73%2Y+0%

Boston Partners manages $54.9B across 642 positions as of Q3 2020. Top holdings: JPM (2.0%), JNJ (1.9%), BRK/B (1.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q3 2020 Summary

Active quarter - 33 new positions, 44 exits, 180 increased. Top move: JNJ (INCREASED, conviction 58). Portfolio: $54.9B across 642 positions.

Top holdings by portfolio weight

Total AUM$55B
JPM1.99%
JNJ1.86%
BRK/B1.53%
AZO1.46%
ETN1.44%
BAC1.40%
PFE1.37%
CI1.19%
CSCO1.19%
TFC1.15%
Other1.09%

Portfolio allocation by GICS sector

Sectors11
Financial Services20.18%
Healthcare16.22%
Industrials14.52%
Technology12.58%
Consumer Cyclical10.65%
Unknown6.16%
Basic Materials4.98%
Communication Services3.33%
Utilities3.31%
Consumer Defensive2.95%
Other5.11%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Healthcare, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L67
Conviction38
Concentration23
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BKVBKVBKV CORP COM
Q4 2024 → Q2 2026+2.5M shares+$69.4M
7Q
INVAINVAINNOVIVA INC
Q4 2024 → Q2 2026+1.6M shares+$37.2M
7Q
KROKROKRONOS WORLDWIDE INC COM
Q4 2024 → Q2 2026+2.3M shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used